Byline: Melissa Rohman
-
Improving Atopic Dermatitis Treatment for Adolescents
Long-term treatment with the drug upadacitinib significantly improved symptoms and quality of life compared to placebo in adolescents with moderate to severe atopic dermatitis after 76 weeks with strong evidence of safety, according to a recent Northwestern Medicine analysis of three international, randomized clinical trials.
-
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes
Treatment with endovascular thrombectomy did not significantly improve outcomes after 90 days in patients with a large core stroke, as compared to patients who received standard stroke care alone, according to a recent clinical trial published in JAMA.
-
Delayed Antibody Treatment May Improve Efficacy of mRNA Vaccines
Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination significantly improved vaccine efficacy in mice, according to findings published in The Journal of Clinical Investigation.
-
Study Identifies Potential Therapeutic Target for PTSD
Targeting a specific neural circuit through noninvasive neuromodulation may reduce symptoms in patients with posttraumatic stress disorder (PTSD), according to a recent study published in Nature Neuroscience.
-
Feinberg Celebrates 100 Years of The Journal of Clinical Investigation
Investigators from Feinberg School of Medicine and fellow academic and research institutions celebrated the 100-year anniversary of The Journal of Clinical Investigation during a day-long symposium in the Hughes Auditorium on October 18.
-
Improving the Science and Treatment of Glioblastoma
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
-
Novel Blood Test Predicts Risk of Severe Lung Disease
Northwestern Medicine investigators have created a novel blood test that identifies adults who may be at increased risk of developing severe respiratory illnesses, according to a recent study published in the American Journal of Respiratory and Critical Care Medicine.
-
Diversity and Inclusion Fall Lyceum Explores Causes of Health Inequity and Possible Solutions
Feinberg students, faculty, trainees and staff gathered in a packed Hughes Auditorium for the Office of Diversity and Inclusion’s annual Fall Lyceum on October 8.
-
Combination Therapy May Improve Treatment Response in Pancreatic Cancer
Northwestern Medicine investigators have discovered that a novel combination treatment promotes cancer cell death and tumor regression in mouse models of pancreatic cancer, providing a rationale for testing in future clinical trials, according to recent findings.
-
Targeting T-cell Lipid Metabolism May Improve Cancer Immunotherapy
Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.
